Skip to main navigation Skip to search Skip to main content

Preclinical development of humanized monoclonal antibodies against CD169 as a broad antiviral therapeutic strategy

  • Patricia Resa-Infante*
  • , Itziar Erkizia
  • , Xabier Muñiz-Trabudua
  • , Federica Linty
  • , Arthur E. H. Bentlage
  • , Daniel Perez-Zsolt
  • , Jordana Muñoz-Basagoiti
  • , D. lia Raïch-Regué
  • , Nuria Izquierdo-Useros
  • , Theo Rispens
  • , Gestur Vidarsson
  • , Javier Martinez-Picado
  • *Corresponding author for this work
  • Generalitat de Catalunya
  • The University of Vic - Central University of Catalonia
  • Germans Trias i Pujol Research Institute (IGTP)
  • Centro de Investigación Biomédica en Red de Enfermedades Infecciosas
  • Sanquin Blood Supply Foundation
  • Utrecht University
  • Amsterdam UMC - University of Amsterdam
  • Amsterdam UMC
  • ICREA

Research output: Contribution to journalArticleAcademicpeer-review

31 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Preclinical development of humanized monoclonal antibodies against CD169 as a broad antiviral therapeutic strategy'. Together they form a unique fingerprint.
Sort by

Keyphrases

Immunology and Microbiology